HRS-6719
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 14, 2025
A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=120 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Solid Tumor
April 10, 2025
A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=120 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.
New P1/2 trial • Solid Tumor
1 to 2
Of
2
Go to page
1